1. Home
  2. UVV vs AMLX Comparison

UVV vs AMLX Comparison

Compare UVV & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$54.14

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.22

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
AMLX
Founded
1886
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
UVV
AMLX
Price
$54.14
$14.22
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.43
AVG Volume (30 Days)
176.2K
1.7M
Earning Date
02-09-2026
03-03-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
N/A
EPS
4.44
N/A
Revenue
$2,987,411,000.00
N/A
Revenue This Year
$3.21
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$12.24
N/A
Revenue Growth
3.01
N/A
52 Week Low
$49.96
$2.60
52 Week High
$67.33
$16.96

Technical Indicators

Market Signals
Indicator
UVV
AMLX
Relative Strength Index (RSI) 55.01 64.81
Support Level $53.53 $12.08
Resistance Level $56.02 $12.50
Average True Range (ATR) 0.89 0.74
MACD 0.16 0.32
Stochastic Oscillator 59.57 89.40

Price Performance

Historical Comparison
UVV
AMLX

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: